Litcius/Paper detail

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination

Gereon Rieke, Kathrin van Bremen, Jenny Bischoff, Michael ToVinh, Malte B. Monin, Stefan Schlabe, Jan Raabe, Kim M Kaiser, Claudia Finnemann, Alexandru Odainic, Anushka Kudaliyanage, Eicke Latz, Christian P. Strassburg, Christoph Boesecke, Susanne V. Schmidt, Benjamin Krämer, Jürgen K. Rockstroh, Jacob Nattermann

2022The Journal of Infectious Diseases28 citationsDOIOpen Access PDF

Abstract

We compared the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike-specific antibodies to induce natural killer cell-mediated antibody-dependent cellular cytotoxicity (ADCC) in patients with natural infection and vaccinated persons. Analyzing plasma samples from 39 coronavirus disease 2019 (COVID-19) patients and 11 vaccinated individuals, significant induction of ADCC could be observed over a period of more than 3 months in both vaccinated and recovered individuals. Although plasma antibody concentrations were lower in recovered patients, we found antibodies elicited by natural infection induced a significantly stronger ADCC response compared to those induced by vaccination, which may affect protection conferred by vaccination.

Topics & Concepts

Antibody-dependent cell-mediated cytotoxicityAntibodyImmunologyVaccinationCytotoxicityVirologyNatural killer cellCoronavirusImmune systemBiologyMedicineDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)In vitroMonoclonal antibodyInternal medicineBiochemistrySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCAR-T cell therapy research